National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

monoclonal antibody L6
A murine IgG2a monoclonal antibody with potential antineoplastic activity. Monoclonal antibody L6 binds to the L6 antigen, a cell surface glycoprotein overexpressed in many carcinomas, and induces antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity against L6-expressing tumor cells. This agent may be conjugated with various toxins in order to target their cytotoxic activity to tumor cells expressing the L6 antigen. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonym:L6
Abbreviation:MOAB L6



Previous:monoclonal antibody HuAFP31, monoclonal antibody HuHMFG1, monoclonal antibody HuM291, monoclonal antibody HuPAM4, monoclonal antibody KW-2871
Next:monoclonal antibody Lym-1, monoclonal antibody m170, monoclonal antibody MDX-060, monoclonal antibody Me1-14 F(ab')2, monoclonal antibody Mik-beta-1

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov